[Form 4] Bunge Global SA Insider Trading Activity

Rhea-AI Filing Summary

Bunge Global SA (BG) has filed a Form 4 reporting that director Adrian Isman was granted 2,164 Restricted Stock Units (RSUs) on 2 July 2025. Each RSU converts into one share of BG common stock at no cost; the award is scheduled to vest on 15 May 2026. Following the grant, Mr. Isman’s direct beneficial ownership stands at 2,164 shares.

The transaction is coded “A” (acquisition) and reflects routine director compensation rather than an open-market purchase. No derivative positions or share disposals were disclosed. Relative to Bunge’s roughly 150 million shares outstanding, the grant represents an immaterial ~0.001 % of total shares and is unlikely to influence dilution, control, or near-term valuation.

Insights

Equity Analyst

TL;DR: Routine RSU grant to BG director; negligible dilution; neutral corporate signal.

The Form 4 shows a standard equity incentive—2,164 RSUs—awarded to director Adrian Isman. The award aligns director interests but, at ~0.001 % of shares outstanding, it is financially immaterial. Because it is a compensation grant rather than an open-market buy, it conveys limited informational value about management’s view on valuation. Overall impact on the investment thesis, earnings outlook, and capital structure is negligible.

Corporate Governance Specialist

TL;DR: Governance-aligned stock award; standard board practice; not market-moving.

Issuing RSUs to non-executive directors is common for S&P 500 agricultural firms like Bunge. The single-year vesting to May 2026 promotes medium-term oversight alignment without creating overhang. There are no performance conditions disclosed, suggesting a vanilla time-based grant. From a governance lens, the filing is routine and carries no material shareholder rights implications.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Isman Adrian

(Last) (First) (Middle)

C/O BUNGE GLOBAL SA

1391 TIMBERLAKE MANOR PARKWAY

(Street)

CHESTERFIELD MO 63017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bunge Global SA [ BG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/02/2025		A		2,164(1)	A	$0	2,164	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of Restricted Stock Units ("RSUs"). One RSU is convertible into one share of Bunge Global SA common stock. RSUs are expected to vest in full on May 15, 2026.

Remarks:

	/s/ Drew Yaeger, Attorney-in-Fact	07/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did BG director Adrian Isman acquire in the Form 4 filing?

Mr. Isman received 2,164 Restricted Stock Units, each convertible into one BG common share.

When will the 2,164 RSUs granted to BG's director vest?

The RSUs are expected to vest in full on 15 May 2026.

Did Adrian Isman buy BG stock on the open market?

No. The Form 4 discloses a compensation grant of RSUs, not an open-market purchase.

What ownership stake does the 2,164-share grant represent in Bunge Global SA?

It equates to roughly 0.001 % of BG’s estimated ~150 million outstanding shares—financially immaterial.